A 2021 update : approach to asthma management in adults

Show simple item record

dc.contributor.author Schellack, Natalie
dc.contributor.author Truter, A.
dc.contributor.author Ntuli, P.N.
dc.contributor.author Mokwele, N.
dc.contributor.author Mogale, K.
dc.contributor.author Esterhuizen, A.
dc.date.accessioned 2022-07-29T06:47:57Z
dc.date.available 2022-07-29T06:47:57Z
dc.date.issued 2021-08
dc.description.abstract Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview of the diagnosis, characterisation and treatment of asthma. en_US
dc.description.department Pharmacology en_US
dc.description.uri http://www.sapj.co.za en_US
dc.identifier.citation Schellack, N., Truter, A., Ntuli, P. N. et al. 2021, 'A 2021 update : approach to asthma management in adults', SA Pharmaceutical Journal, vol. 88, no. 4, pp. 17-24, doi : 10.520/ejc-mp_sapj_v88_n4_a6. en_US
dc.identifier.issn 2220-1017 (online)
dc.identifier.issn 2221-5875 (print)
dc.identifier.other 10.520/ejc-mp_sapj_v88_n4_a6
dc.identifier.uri https://repository.up.ac.za/handle/2263/86581
dc.language.iso en en_US
dc.publisher Medpharm Publications en_US
dc.rights Medpharm Publications. This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. en_US
dc.subject Asthma en_US
dc.subject Bronchodilator en_US
dc.subject Inhaled corticosteroid en_US
dc.subject β-agonist en_US
dc.subject Spirometry en_US
dc.subject Peak expiratory flow en_US
dc.subject Short-acting β2-agonist (SABA) en_US
dc.subject Long-acting β2-agonist (LABA) en_US
dc.title A 2021 update : approach to asthma management in adults en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record